Intas may acquire poultry drug unit

Intas is a major player in the Indian pharmaceutial industry manufacturing drugs for livestock and in companion animal segment. The company is now looking at consolidating its animal healthcare business as it is considering the acquisition of a drug manufacturing unit in the poultry segment.

“We are keen to acquire units that are into poultry drug manufacture,” said Vijay Teng, vice president, Neovet, adding that the acquisition would be between Rs 30 crore and 40 crore for the poultry segment.

The company has, until now, not entered the poultry drug segment as the poultry sector is a highly price-sensitive sector. According to Teng, with the improvement of the sector, it is more stable in terms of drug price.